Bio Protocol raises $6.9M to launch its AI-native decentralized science platform, ensuring faster biotech funding and drug discovery, led by Maelstrom Fund.
Amount Raised
$6.9 Million
Round Type
Funding Round
Investors
Description
Bio Protocol has raised $6.9 million in a funding round led by Maelstrom Fund, with contributions from notable biotech and crypto investors. This funding will support Bio Protocol's expansion into a comprehensive platform for AI-driven decentralized science and drug discovery. The platform aims to unite researchers, patients, and crypto users in accelerating scientific innovation. With new standards in funding and research capabilities, Bio Protocol seeks to revolutionize how biotech progresses from ideas to market-ready solutions.
Who to call at Bio Protocol, and when
A new round usually means Bio Protocol is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Bio Protocol raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Bio Protocol, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Bio Protocol. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Bio Protocol raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Bio Protocol raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.